Navigation Links
Marken Validates Top Position in Global Clinical Sample Shipments
Date:3/15/2012

PARIS, March 15, 2012 /PRNewswire/ --  Marken is pleased to share its year-end data which validates that it holds a market-leading position in the shipment of in-bound biological samples to the major central laboratories and to Pharma directly.  In the past 18 months, Marken collected shipments from over 49,000 clinical investigators in 159 countries around the world.  An independent survey* conducted by a major consulting group, confirms that Marken has more than 60% of the specialty courier market in biological samples transportation, and a higher share of the cold chain segment of that same market. Marken also commissioned an in-depth market research study in 2011 with The Avoca Group.  The Avoca Group interviewed over 100 individuals, including current clients, from 74 global pharmaceutical, CRO, laboratory, and sponsor companies who use supply chain services. In the survey, Marken achieved the top score when asked "Who do you consider a leader in clinical trial logistics?"  The qualities attributed to Marken's leading position were cost effectiveness, flexibility, on-time performance and customer service. Marken intends to conduct this survey annually as a means to monitor and improve its client service position.

(Logo: http://photos.prnewswire.com/prnh/20110930/NY78064LOGO )

With its recent expansion in India and continued growth in Asia, Marken continues to broaden its reach and existing outbound shipments for the pharmaceutical industry which will include: drug product shipments, patient kit shipments, active pharmaceutical ingredients (API) shipments and medical devices.  To support the growing demand, Marken has accelerated its development of pharmaceutical service depots in Asia, Europe, North America and Latin America whilst ensuring that the stringent Quality and Performance criteria of the temperature controlled supply chain are met.

"We are pleased to share the 2011 results from our independent research. The growth in biologics and the increasing need for temperature controlled supply chain will encourage more of our clients to use Marken for their time and temperature sensitive shipments," said Wes Wheeler, Marken's CEO.  "We are experts in worldwide collection of patient samples which is derived from the personal visits we make to 49,000 clinical investigators in 159 countries. We have leveraged this expertise to our growing outbound business as well and will continue to expand our reach with new locations and new distribution services in the life science industries."

About Marken
Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies.

*Survey Study Funded by Marken


'/>"/>
SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Marken Opens New Corporate Offices
2. Marken Strengthens Clinical Trial Distribution Capabilities
3. Marken Appoints New Head of Global Quality Assurance
4. Marken Announces Its New Logistics Operating System: Maestro™
5. Marken Announces Appointment of Christopher OConnell as New Chief Financial Officer
6. Marken Announces the Opening of a Directly Owned Clinical Trial Supply Depot in Singapore
7. Marken Rapidly Responds to Global Supply Chain Security Measures
8. Marken Unveils New Japan Office
9. New Research Validates Results of Previous Studies Demonstrating Tru-D® (Lumalier Corporation) Significantly Reduces Environmental Contamination on Surfaces in Patient Rooms
10. Study Validates Clinical Accuracy of 50% Dose Reduction for Positron Emission Mammography
11. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... Feb. 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... editing, today reported its fourth quarter and full ... in vivo therapeutic genome editing," said Edward ... zinc finger nuclease (ZFN) technology leads the therapeutic ... core competencies necessary to move our ground-breaking genome ...
(Date:2/9/2016)... HAMILTON, Bermuda, Feb. 9, 2016  Axovant Sciences ... focused on the treatment of dementia, today announced ... address cognitive, behavioral and functional aspects of Lewy ... people in the U.S. Two out of the ... is expected to start later this quarter. In ...
(Date:2/9/2016)... The new report "Global Diagnostic Ultrasound Devices Market Assessment & Forecast: ... global diagnostic ultrasound devices market was valued at US$ 5,381.1 million ... 2019 at a CAGR of 6.8% from 2015 to 2019. ... analyzed for six geographies of North America , ... Latin America , Middle-East and ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Boston Store, Carson’s, Elder-Beerman, Herberger’s and Younkers department stores, announced it has raised ... of Wisconsin Cancer Center, Holden Comprehensive Cancer Center at the University of Iowa, ...
(Date:2/9/2016)... San Diego, California (PRWEB) , ... February 09, ... ... the launch of their new nationwide service to expand access to affordable ... over 30 million hard of hearing individuals in the United States. , “For ...
(Date:2/9/2016)... Florida (PRWEB) , ... February 09, 2016 , ... ... cold therapy products, announced today the introduction of the newly designed, innovative shoulder ... comfort and better cold therapy coverage for the injured arm and shoulder to ...
(Date:2/9/2016)... ... 09, 2016 , ... United Methodist Communications collaborated with Chocolate ... animated video designed to prevent the next widespread Ebola outbreak from ... being distributed throughout Togo, Liberia, Sierra Leone, Nigeria, Côte d’Ivoire and other African ...
(Date:2/9/2016)... ... February 09, 2016 , ... i2i Systems, an early innovator and ... data vendors in the latest KLAS report, Population Health Management 2015: How Far Can ... market for population health management (PHM). The latest KLAS Report, leveraging over 200 ...
Breaking Medicine News(10 mins):